AAAAAA

   
Results: 1-11 |
Results: 11
ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2
Authors: FOON KA SEN G HUTCHINS L KASHALA OL BARAL R BANERJEE M CHAKRABORTY M GARRISON J REISFELD RA BHATTACHARYACHATTERJEE M
Citation: Ka. Foon et al., ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2, Clinical cancer research, 4(5), 1998, pp. 1117-1124
ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2
Authors: FOON KA SEN G HUTCHINS L KASHALA OL BARAL R BANERJEE M CHAKRABORTY M GARRISON J REISFELD RA BHATTACHARYACHATTERJEE M
Citation: Ka. Foon et al., ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2, Clinical cancer research, 4(5), 1998, pp. 1117-1124
PREVENTING HETEROSEXISM AND HOMOPHOBIA - ROTHBLUM,E, BOND,L
Authors: HUTCHINS L
Citation: L. Hutchins, PREVENTING HETEROSEXISM AND HOMOPHOBIA - ROTHBLUM,E, BOND,L, Journal of sex & marital therapy, 24(2), 1998, pp. 145-147
BISEXUALITIES AND AIDS - INTERNATIONAL PERSPECTIVES - AGGLETON,P
Authors: HUTCHINS L
Citation: L. Hutchins, BISEXUALITIES AND AIDS - INTERNATIONAL PERSPECTIVES - AGGLETON,P, Journal of sex & marital therapy, 23(2), 1997, pp. 160-162
QUALITY-CONTROL OF SPIROMETRY TESTING IN THE REGISTRY FOR PATIENTS WITH SEVERE ALPHA(1)-ANTITRYPSIN DEFICIENCY
Authors: STOLLER JK BUIST AS BURROWS B CRYSTAL RG FALLAT RJ MCCARTHY K SCHLUCHTER MD SOSKEL NT ZHANG R BENGALI Z DESHLER J VREIM CE ROTHGEB A WU M SNIDER GL DETRE K REYNOLDS HY TOCKMAN MS WITTES J COHEN A GADEK JE ROUSELL RH SCHWARTZ RS TURINO GM BRANTLY ML HURD S WILLIAMS GW AJAMOUGHLI R BECK GJ CONNELLY RP DOBISH B GOORMASTIC M LEATHERMAN J MCMAHAN J MIDCALF V MOORE B SARTORI P SHERER SG SWINDERMAN D TUASON M WIEDEMANN HP DOBISH ME PETTY TL HILDESHEIM J RUNDQUIST B SANDHAUS RA BELL CW BEREND J BURRY CA IRVINE K KRANTZ D LEWIS S RAVIKRISHNAN KP BEGLE R CAMERON B COTTON S SEIDMAN J SHERMAN S TRUE M WEINBERGER S ARMSTRONG K JOHNSTON R ROSENBERG M LAROCK JB MORIYAMA L WILLARD K ARROLIGA AC MEEKER DP CASSIDY E GOLISH JA HUTCHINS L LASKOWSKI D MEHTA A PAGLIACCIO L PILLAR R RHODES G SCOTT J SOENTJEN L RYAN WJ JOHNSON K LOFTIN JP KOTCH A CLARK T EPSTEIN PE DELBUONO P SANDBLOM RE COLLAR L CURTIS M DEMAINE JB MELSON B EICHENHORN MS BEAUCHAMP R HUPFER S LUKASZEK C MACKEWICH R WILSON C BREITE WM MCMAHAN JP DEATLEY R MYLET D WILLIAMS T WEBBJOHNSON D CORBETT J JUDD L MCMANUS D PIERCE J KROWKA MJ AWAN Z FEHRENKAMP R MADDEN M SCHULTZ K WHEATLEY N PRAKASH UBS NESLER D SCOTT L SCANLON P STAATS B VIGGIANO R STRANGE C BAUMANN M BURNS B JUDSON M OSER R YOUMANS M KILLIAN DN DEMICCO W GOLDEN L HESS SA HITCHCOCK R RAYMOND G MOSS J BARNES P CZERSKI D HEALY J JOLLEY C MCELVANEY NG ROBINSON W TAYLOR G METH BM HOLDEN D ASHBURN RW CROWDER G DOLENSKY R HAMILTON C JONES S FORRESTER J SARLIN RF SEN RP SHELTON B SCHULER B TYLER M WALSH TE ZARATE J WEWERS M DRAKE J JAMES B SWANK B BARKER AF DSILVA R OVESON L WINTHER L SHEEHAN WC AISENBERG RM CHADBOURNE L DEMERS P LITTLE P MUCCIARDI N OLIVERAWILLIAMS D SHEEHAN A EDEN E KLUGH T PARMAR SI MIDDLETON ML MONTAGUE D KLINK M BEELER EP BOYER B CLINE M GORDON D CROSS CE BOOTH JA CHAN A FEKETE R KEMNITZ H VOLZ W TIERNEY DF EZELL L HAUGH J SHAPIRO B CLAUSEN JL BORDERS J DENT C FONZI C FORD R KING SJ LOPEZ C WILSON J BUCHMAYER J ANDERSON M BITTERMAN P DOSLAND B EDIN C HARMON K HERTZ M KRAUSE S LINDQUIST P LOVENBELL M PLOOSTER K RENNARD SI CHENEY R CIRIAN D DIAMOND J EPPERSON K FOGLEMAN R HOUCHINS J JONES K MCGRANAGHAN S PIGNOTTI T PURSEL T ROBBINS RA DONOHUE JF DAVIS L HOHNEKER KW HORNADAY B MASCRELLA J SOBOL L TURPIN S HYDE RW LYNCH R SPOHN B GRISHAM C JONES C PATRICK T STOCKS JM BLEVINS WJ FIELDS S HINOJOSA J WALDROP D WILSON E KANNER RE CAMPBELL EJ BEHNKE J POPE K THELANDER C GROSS N KING F WATERS I MACNEILL L NELSON P HOROWITZ M FRANKLIN B JENKERSON M PIERCE JA SILVERMAN E STORY N WADE M WILSON P
Citation: Jk. Stoller et al., QUALITY-CONTROL OF SPIROMETRY TESTING IN THE REGISTRY FOR PATIENTS WITH SEVERE ALPHA(1)-ANTITRYPSIN DEFICIENCY, Chest, 111(4), 1997, pp. 899-909
RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
Authors: CRAWFORD J OROURKE M SCHILLER JH SPIRIDONITIS CH YANOVICH S OZER H LANGLEBEN A HUTCHINS L KOLETSKY A CLAMON G BURMAN S WHITE R HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA
Authors: ELLIS GK HUTCHINS L JIMENEZMARTIN M PECORA AL BARNADAS A MEISENBERG B NABHOLTZ JM CORTESFUNES H RIFKIN R CHANG AYC GARRISON L GEORGE C GILES FJ
Citation: Gk. Ellis et al., PHASE-III DOUBLE-BLIND RANDOMIZED STUDY OF PIXY321 VERSUS GCSF AFTER CEP FOR BREAST OR OVARIAN-CARCINOMA, Blood, 88(10), 1996, pp. 1783-1783
INTRAVENOUS VINORELBINE AS FIRST-LINE AND 2ND-LINE THERAPY IN ADVANCED BREAST-CANCER
Authors: WEBER BL VOGEL C JONES S HARVEY H HUTCHINS L BIGLEY J HOHNEKER J
Citation: Bl. Weber et al., INTRAVENOUS VINORELBINE AS FIRST-LINE AND 2ND-LINE THERAPY IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2722-2730
RANDOMIZED COMPARISON OF VINORELBINE AND MELPHALAN IN ANTHRACYCLINE-REFRACTORY ADVANCED BREAST-CANCER
Authors: JONES S WINER E VOGEL C LAUFMAN L HUTCHINS L OROURKE M LEMBERSKY B BUDMAN D BIGLEY J HOHNEKER J
Citation: S. Jones et al., RANDOMIZED COMPARISON OF VINORELBINE AND MELPHALAN IN ANTHRACYCLINE-REFRACTORY ADVANCED BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2567-2574
PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 1ST-LINE OR 2ND-LINE THERAPY FOR ADVANCED BREAST-CANCER
Authors: MARGOLIN KA GREEN S OSBORNE K DOROSHOW JH AKMAN SA LEONG LA MORGAN RJ RASCHKO JW SOMLO G HUTCHINS L UPCHURCH C
Citation: Ka. Margolin et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID AS 1ST-LINE OR 2ND-LINE THERAPY FOR ADVANCED BREAST-CANCER, American journal of clinical oncology, 17(2), 1994, pp. 175-180
PREDICTORS OF SURVIVAL FOLLOWING RELAPSE OR PROGRESSION OF SMALL-CELLLUNG-CANCER - SOUTHWEST-ONCOLOGY-GROUP STUDY 8605 REPORT AND ANALYSISOF RECURRENT DISEASE DATA-BASE
Authors: ALBAIN KS CROWLEY JJ HUTCHINS L GANDARA D OBRYAN RM VONHOFF DD GRIFFIN B LIVINGSTON RB
Citation: Ks. Albain et al., PREDICTORS OF SURVIVAL FOLLOWING RELAPSE OR PROGRESSION OF SMALL-CELLLUNG-CANCER - SOUTHWEST-ONCOLOGY-GROUP STUDY 8605 REPORT AND ANALYSISOF RECURRENT DISEASE DATA-BASE, Cancer, 72(4), 1993, pp. 1184-1191
Risultati: 1-11 |